Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Qbts, what's your thoughts on this one?
You must be retired.
Thanks for posting. SRNE will save lives down there!
All these tests are now available or will be soon. The whole article is more informative see the link below. Don't get me wrong I've owned SRNE for almost 3 years.
https://na01.safelinks.protection.outlook.com/?url=http%3A%2F%2Faction.aarp.org%2Fsite%2FR%3Fi%3DDL6-yfIKAteuaSIo4bE0KA&data=04%7C01%7C%7C515d85e242a84827894508d8b8db159e%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637462598388486675%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=nMar25QyRoJZJ14QkLpAyVhLHA6civGAxb%2FFqRz0F9w%3D&reserved=0e
In my mailbox from AARP this morning.
Comparison of at-home COVID-19 rapid tests
Ellume COVID-19 Home Test
Where/when to find it: Sold over the counter at pharmacies and retail stores. Distribution is slated to start in January.
Type of test: Antigen
Does it require a prescription? No
Cost: About $30
Who can use it: People with or without coronavirus symptoms as young as 2 years old
How long to get results: About 15-20 minutes
You need to know: Sold over the counter and does not require a prescription or COVID symptoms.
BinaxNOW COVID-19 Ag Card Home Test
Where/when to find it: Expected to be available in a few states in January, with widespread distribution later in 2021. Order the test through a digital health platform called eMed.
Type of test: Antigen
Does it require a prescription? Yes. If a telehealth rep determines you are eligible, a test will be shipped overnight to your home or you may pick it up locally.
Cost: $25, plus the overnight shipping fee
Who can use it: People age 4 or older suspected by a health care provider of infection within the first 7 days of symptom onset
How long to get results: About 15 minutes
You need to know: A telehealth guide via video call will walk you through the collection process, answer questions and help you understand the results.
Lucira COVID-19 All-In-One-Test Kit
Where/when to find it: Expected to be available in early spring. The test will be delivered to your home after a doctor writes you a prescription for it.
Type of test: Molecular
Does it require a prescription? Yes. The test must be prescribed by a health care provider.
Cost: About $50
Who can use it: People age 14 and older suspected by their health care provider to be infected with the virus
How long to get results: 30 minutes or less
You need to know: The only at-home test that uses molecular technology, which is considered more accurate because it can pick up lower levels of the virus than antigen technology.
NNDM-thanks, looks like it still had juice.
NNDM, thanks for the heads up this morning. In @ $1.27, couldn't hold my breath anymore so all out at $2.88.
SNES, might want to wait till after the 1/20 reverse split tomorrow.
VXRT, nice 21% gain thus far.
VXRT- Thanks Mark, these guys should be trading in the dollars. Looking at what they are doing is pretty impressive.
New SEC 6-K filing out with the new corporate presentation. Looks pretty good.
You must be a trader. I've held some CHEK for a couple of years now, traded some this morning and bought them back this afternoon. Mainly I'm here for the long haul. CHEK just needs to keep developing their product. I don't see them doing much for another 18 months unless there's a buy out. I'm in that age group where I need to do a colorectal test every few years, hate that stuff. Looking for the day I can do a C-Scan. Swallow and forget. Good luck to you.
Check-Cap Announces Positive Final Results from Its Post-CE Approval Study of the C-Scan(R) System
6:30 am ET July 9, 2019 (PR Newswire)
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan(R), the first and only preparation-free capsule based screening method for the prevention of colorectal cancer through the detection of precancerous polyps, today announced positive final results from its recently completed post-CE approval study evaluating the clinical performance and safety of the C-Scan system.
https://mma.prnewswire.com/media/820848/Check_Cap_Logo.jpg
So sorry to hear, thoughts and prayers for you and your family.
All in all its been a pretty good week.
CHEK-up 15% @ $4.07 (high was $4.20) news is expect this month.
CHEK-3.60 +0.31 (9.42%) Pre-Market: 8:00AM ESTCheck-Cap Announces FDA Conditional Approval of IDE to Initiate U.S. Pilot Study of C-Scan®
CHEK - Thanks, they had an offering in June 2018 for $20 mil and state, "Management expects that the Company's existing cash will be sufficient to fund the Company's projected operating requirements into October 2019".But you know how that goes sometimes. All depends on getting the product approved and to market. Appreciate your input!!
CHEK, check CHEK, what's your thoughts, hold?
I'll bend the knee for your post! Very well put.
MNGA: MagneGas Corp Receives First Order for Wastewater Treatment Following Years of Application Development
MNGA: MagneGas Announces Financing Transaction
MagneGas Corporation ("MagneGas" or the "Company") (NASDAQ: MNGA), a leading clean technology company in the renewable resources and environmental solutions industries, announced today that it has entered into a securities purchase agreement with certain existing and new institutional accredited investors to purchase upto approximately $850,000 of its common stock and warrants to purchase Series D convertible preferred stock.
At the initial closing under the securities purchase agreement, the Company will issue to the investors a total of 150,000 shares of common stock at a purchase price of $1.00 per share. The remainder of the funding will be made available to the Company through the exercise of the warrants being issued in the offering based on market conditions. The warrants will be exercisable for up to 694,422 shares of the Company's Series D convertible preferred stock at an exercise price of $1.00 per share. Terms of the financing and related agreements were disclosed in the Company's Form 8-K filed with the Securities and Exchange Commission on July 24, 2017.
DRYS - looks like the float is about to be traded today, could mean shares being added. Wonder what the float will be tomorrow? Good luck to you.
MNGA-reverse split and dilution.
TAMPA, Florida, May 19, 2017 /PRNewswire/ --
MagneGas Corporation (MNGA), today announced that it has filed a Certificate of Amendment to its Certificate of Incorporation to effect a 1-for-10 reverse stock split, effective as of 5:00 p.m. Eastern Time today. The reverse stock split was effected by MagneGas in accordance with the authorization adopted by MagneGas stockholders at the Special Meeting of Stockholders held on May 17, 2017.
Also going from 90mil to 190mil on the share structure.
DRYS-1 for 7 reverse split this am. Their fifth in 10 months.
CETX - all out, sold 3500 shares at 3.60. Nice 25% gain since entry. Look at getting back in after all the excitement clears.
Oh man, for a second there you had me!!!
XRA- sold 2/3s this am at $1.84. Holding a few for Gold Corp shares. What the heck this was totally a nice surprise. Thanks again.
XRA - as I recall this was your recommendation back in December at around $.68 per share. I've been accumulating since then. Owe you a big one on this.
XRA - Thanks AF, this one came in very very nice! In from $.82.
Exeter to Be Acquired by Goldcorp for Total Consideration of C$247M>XRC
Dow Jones
MNGA - News - MagneGas Expands Into Commercial CO2 Market
PR Newswire
Link- http://ir.stockpr.com/magnegas/news/detail/2550
PTN - BIG news out. PTN market cap currently only in the mid 70's.
Under the terms of the license agreement, AMAG will pay to Palatin $60 million of total upfront consideration, up to $80 million contingent upon achieving certain regulatory milestones and up to $300 million contingent upon meeting certain sales milestones. The first sales milestone is $25 million and would be triggered when Rekynda annual net sales in North America exceed $250 million. Additionally, AMAG expects to reimburse Palatin for up to $25 million of ongoing development expenses incurred by Palatin in connection with the remaining development of Rekynda in 2017. AMAG will also pay Palatin tiered royalties on net sales ranging from high single-digit to low double-digit percentages. AMAG expects the transaction to close in the first quarter of 2017.
GPL - NICE, closed at the high of day, $1.40. Thanks for all you and the other mods do on this great board!!!!
NAK - Interesting article out on SA if you haven't read it yet. "Stock Idea For An Upcoming Hillary Victory".
CXRX, thank you Donis, I'm out with a nice 35% gain.
RGNX, in at $11.23. See its at $12.07 now. Nice pick Matt, thanks for the heads up.
UAMY, they are a very small (less than $10m in 2015 sales)and hardly followed industrial metals miner with potential. They are not much on the precious metals side, only sold 90 ounces of gold last year and 30k silver as by products. The thing I like about them is that they are now financing growth from cash flow and the precious metals will only get better. I think we see 20 plus percent growth out of them this year. I have a few shares with a long term outlook.
UAMY, forget the gold look at the silver projections for Bear River, 8,222 ounces a month?? That would come in at close to 100k ounces a year at that facility. I think these guys are going to give us some impressive numbers $$ over the coming months.
U.S. Antimony Reports Strong Zeolite Sales.
Gold at $1348, silver knocking on $20.40. Happy Fourth of July!!